Elliott Sun

Elliott Sun is a Senior Associate at LYFE Capital since July 2021, focusing on therapeutic investments from Series A to IPO and late-stage private equity opportunities in CDMO and supply chains across the US and Asia. Prior to this role, Elliott Sun was an Associate at Baidu Venture from April 2020 to July 2021, where involvement included corporate strategy, investment in biotech, and serving as a founding team member of Biomap Inc., an AI biotech spin-off. Additional experience includes an Analyst position at Baidu Venture, participation in the Oxford Saïd Finance Lab, and legal and research roles at DeHeng Law Offices and Hokkaido University, respectively. Elliott Sun holds a PhD in Medical Sciences from the University of Oxford, an MSc with distinction in Cancer from UCL Cancer Institute, and dual undergraduate degrees in Biochemical Engineering and Law from Xiamen University.